Suscribirse

Bile-pancreatic juice replacement not cholinergic-and cholecystokinin-receptor blockade reverses acinar cell hyperstimulation after bile-pancreatic duct ligation - 11/09/11

Doi : 10.1016/S0002-9610(99)80101-9 
Isaac Samuel, MD, Raymond J. Joehl, MD
 From the Department of Surgery, Northwestern University Medical School, and Surgical and Research Services, Veterans Affairs Medical Center (Lakeside), Chicago, Illinois, USA 

**Requests for reprints should be addressed to Raymond J. Joehl, MD, Department of Surgery, Northwestern University Medical School, 250 E Superior Street, Suite 201, Chicago Illinois 60611-2950.

This study was presented at the Tenth Annual Meeting of the Society for Surgery of the Alimentary Tract/Ross Laboratories Residents and Fellows Research Conference, La Jolla, California, May 13, 1995, and at the 36th Annual Meeting of the Society for Surgery of the Alimentary Tract, San Diego, California, May 14–17, 1995. It was previously published as an abstract [Am J Surg 1995;169:455].

Abstract

Background

Acinar cell inhibitors (eg, atropine) fail to ameliorate clinical and experimental acute pancreatitis. We hypothesized that amelioration of pancreatic acinar cell hyperstimulation after bile and pancreatic duct ligation is better with gut replacement of bile and pancreatic juice than with cholinergic- and cholecystokinin (CCK)-receptor blockade.

Methods

Using acinar cell amylase activity as an index of hyperstimulation, we studied 63 rats in two sets of experiments. Bile-pancreatic juice exclusion from gut—without (set one) and with (set two) bile and pancreatic duct obstruction— was treated with atropine and CCK-receptor antagonist L-364,718, or with enterai replacement of bile-pancreatic juice.

Results

In the set one experiment, acinar cell hyperstimulation after bile-pancreatic; juice exclusion was reversed by combined L-364,718 and atropine pretreatment. In set two, acinar cell hyperstimulation after bile and pancreatic duct ligation was reversed by enterai bile and pancreatic juice replacement, but not by combined L-364,718 and atropine pretreatment.

Conclusions

According to this experimental corollary of early gallstone impaction, prevention of acinar cell hyperstimulation after duct occlusion should be aimed at the source of the response to bile-pancreatic juice exclusion, namely, the gut, rather than at the target of the response, the pancreatic acinar cell.

El texto completo de este artículo está disponible en PDF.

* This work was supported by a Merit Review Grant from Medical Research Service, Department of Veterans Affairs, Washington, D.C.; and by a Research Fellowship (IS) from the Department of Surgery, Northwestern University Medical School, Chicago, Illinois.


© 1996  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 171 - N° 1

P. 207-211 - janvier 1996 Regresar al número
Artículo precedente Artículo precedente
  • Hepatic tumor necrosis factors production and distant organ dysfunction in a murine model of obstructive jaundice
  • Elizabeth A. Beierle, Jean-Nicolas Vauthey, Lyle L. Moldawer, Edward M. Copeland
| Artículo siguiente Artículo siguiente
  • Contractile properties of enteric smooth muscle after small bowel transplantation in rats
  • Michel M. Murr, Virginia M. Miller, Michael G. Sarr

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.